Metabolic restaging of hepatocellular carcinoma using whole-body 18F-FDG PET/CT

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Hepatol. Oct 31, 2009; 1(1): 90-97
Published online Oct 31, 2009. doi: 10.4254/wjh.v1.i1.90

Table 2 Characteristics of recurrent HCC in 17 true positive patients

Characteristics	n
Intrahepatic recurrence	8
Intrahepatic recurrence and extrahepatic metastases	5
Extrahepatic metastases without intrahepatic recurrence	4
Single intrahepatic recurrence	7
Multiple intrahepatic recurrence	8
Lung	4
Bone	1
Omentum and mesentery	3
Retroperitoneal lymph nodes	2
Adrenal	1

Citation: Sun L, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H. Metabolic restaging of hepatocellular carcinoma using whole-body ¹⁸F-FDG PET/CT. World J Hepatol 2009; 1(1): 90-97
URL: https://www.wjgnet.com/1948-5182/full/v1/i1/90.htm
DOI: https://dx.doi.org/10.4254/wjh.v1.i1.90

Sun L, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H. Metabolic restaging of hepatocellular carcinoma using whole-body ¹⁸F-FDG PET/CT. World J Hepatol 2009; 1(1): 90-97 [PMID: 21160970 DOI: 10.4254/wjh.v1.i1.90]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.